Kovack Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
Kovack Advisors's FTXH Position: Q3 2026 in Review
Kovack Advisors opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 26,320 shares worth $1.08M. The stake represents 0.05% of the portfolio and ranks #368 among its holdings. This is a return to the name: Kovack Advisors previously reported a position in FTXH as recently as Q2 2021.
Kovack Advisors first reported a position in FTXH in Q1 2021 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.
- Kovack Advisors held 26,320 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.08M as of Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF was a new Kovack Advisors position in Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF made up 0.05% of Kovack Advisors's portfolio in Q3 2026, its #368 holding.
- Kovack Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2021 and has held it in 3 quarters since.
- 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.